Return On Equity of CHINA PHARMA HOLDINGS, INC. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
CHINA PHARMA HOLDINGS, INC. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • CHINA PHARMA HOLDINGS, INC. Return On Equity for the quarter ending 30 Sep 2025 was -43%, a 32% increase year-over-year.
  • CHINA PHARMA HOLDINGS, INC. annual Return On Equity for 2024 was -63%, a 16% decline from 2023.
  • CHINA PHARMA HOLDINGS, INC. annual Return On Equity for 2023 was -55%, a 43% increase from 2022.
  • CHINA PHARMA HOLDINGS, INC. annual Return On Equity for 2022 was -96%, a 88% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

CHINA PHARMA HOLDINGS, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -43% +21% +32% 01 Jul 2025 30 Sep 2025
Q2 2025 -53% +7.4% +12% 01 Apr 2025 30 Jun 2025
Q1 2025 -64% -9.4% -17% 01 Jan 2025 31 Mar 2025
Q4 2024 -63% -8.7% -16% 01 Oct 2024 31 Dec 2024
Q3 2024 -64% +0.13% +0.2% 01 Jul 2024 30 Sep 2024
Q2 2024 -60% +17% +22% 01 Apr 2024 30 Jun 2024
Q1 2024 -54% +32% +37% 01 Jan 2024 31 Mar 2024
Q4 2023 -55% +42% +43% 01 Oct 2023 31 Dec 2023
Q3 2023 -64% +17% +21% 01 Jul 2023 30 Sep 2023
Q2 2023 -77% -10% -15% 01 Apr 2023 30 Jun 2023
Q1 2023 -86% -27% -46% 01 Jan 2023 31 Mar 2023
Q4 2022 -96% -45% -88% 01 Oct 2022 31 Dec 2022
Q3 2022 -81% -30% -59% 01 Jul 2022 30 Sep 2022
Q2 2022 -67% -15% -30% 01 Apr 2022 30 Jun 2022
Q1 2022 -59% -21% -56% 01 Jan 2022 31 Mar 2022
Q4 2021 -51% -16% -46% 01 Oct 2021 31 Dec 2021
Q3 2021 -51% +190% +79% 01 Jul 2021 30 Sep 2021
Q2 2021 -52% +99% +66% 01 Apr 2021 30 Jun 2021
Q1 2021 -38% +75% +67% 01 Jan 2021 31 Mar 2021
Q4 2020 -35% +51% +59% 01 Oct 2020 31 Dec 2020
Q3 2020 -241% -208% -639% 01 Jul 2020 30 Sep 2020
Q2 2020 -151% -117% -348% 01 Apr 2020 30 Jun 2020
Q1 2020 -113% -82% -263% 01 Jan 2020 31 Mar 2020
Q4 2019 -86% -58% -207% 01 Oct 2019 31 Dec 2019
Q3 2019 -33% +8.3% +20% 01 Jul 2019 30 Sep 2019
Q2 2019 -34% +3.7% +10% 01 Apr 2019 30 Jun 2019
Q1 2019 -31% +5.7% +15% 01 Jan 2019 31 Mar 2019
Q4 2018 -28% +7.7% +22% 01 Oct 2018 31 Dec 2018
Q3 2018 -41% -26% -167% 01 Jul 2018 30 Sep 2018
Q2 2018 -37% -23% -165% 01 Apr 2018 30 Jun 2018
Q1 2018 -37% -23% -167% 01 Jan 2018 31 Mar 2018
Q4 2017 -36% -22% -155% 01 Oct 2017 31 Dec 2017
Q3 2017 -15% +15% +50% 01 Jul 2017 30 Sep 2017
Q2 2017 -14% +8.5% +38% 01 Apr 2017 30 Jun 2017
Q1 2017 -14% +2.8% +17% 01 Jan 2017 31 Mar 2017
Q4 2016 -14% +4.8% +25% 01 Oct 2016 31 Dec 2016
Q3 2016 -31% -5.2% -20% 01 Jul 2016 30 Sep 2016
Q2 2016 -23% +10% +31% 01 Apr 2016 30 Jun 2016
Q1 2016 -17% +23% +58% 01 Jan 2016 31 Mar 2016
Q4 2015 -19% +16% +46% 01 Oct 2015 31 Dec 2015
Q3 2015 -25% 01 Jul 2015 30 Sep 2015
Q2 2015 -33% 01 Apr 2015 30 Jun 2015
Q1 2015 -40% 01 Jan 2015 31 Mar 2015
Q4 2014 -35% 01 Oct 2014 31 Dec 2014
Q1 2012 12% 01 Jan 2012 31 Mar 2012

CHINA PHARMA HOLDINGS, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -63% -8.7% -16% 01 Jan 2024 31 Dec 2024
2023 -55% +42% +43% 01 Jan 2023 31 Dec 2023
2022 -96% -45% -88% 01 Jan 2022 31 Dec 2022
2021 -51% -16% -46% 01 Jan 2021 31 Dec 2021
2020 -35% +51% +59% 01 Jan 2020 31 Dec 2020
2019 -86% -58% -207% 01 Jan 2019 31 Dec 2019
2018 -28% +7.7% +22% 01 Jan 2018 31 Dec 2018
2017 -36% -22% -155% 01 Jan 2017 31 Dec 2017
2016 -14% +4.8% +25% 01 Jan 2016 31 Dec 2016
2015 -19% +16% +46% 01 Jan 2015 31 Dec 2015
2014 -35% -20% -145% 01 Jan 2014 31 Dec 2014
2013 -14% -17% -553% 01 Jan 2013 31 Dec 2013
2012 3.1% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.